The Ras Project: Overview The clinical need • High incidence of RAS mutations in cancer • No drugs that target RAS proteins directly or indirectly • No therapies effective for RAS-driven cancers - GTP-binding protein regulators - Document - PDFSEARCH.IO

First Page	Meta Content
	The Ras Project: Overview The clinical need • High incidence of RAS mutations in cancer • No drugs that target RAS proteins directly or indirectly • No therapies effective for RAS-driven cancers Add to Reading List Document Date: 2013-07-01 12:40:11 Open Document File Size: 280,70 KB Share Result on Facebook MedicalCondition cancers / RAS cancers / KRAS cancer / human cancer / RAS-driven cancers / cancer / NRAS Melanoma / established cancers / KRAS cancers / / Technology drug delivery / drug discovery / / SocialTag GTP-binding protein regulators Proteins Ras subfamily Cetuximab GTPase-activating protein HRAS Cancer Biology KRAS Medicine

The Ras Project: Overview The clinical need • High incidence of RAS mutations in cancer • No drugs that target RAS proteins directly or indirectly • No therapies effective for RAS-driven cancersAdd to Reading List